News
11h
MedPage Today on MSNMarginal Benefits in High-Risk Ovarian Cancer With Addition of Bevacizumab to ChemoPatients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab ...
Kate, Britain's Princess of Wales, said nature had been her sanctuary over the last year in which she underwent preventative ...
5h
Verywell Health on MSNWhat Happens When Hormone Treatment for Prostate Cancer Stops Working?Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...
Findings from a new study show that exercise helps reduce side-effects of cancer treatment such as nausea, ...
11h
HealthDay on MSNAdding Bevacizumab to Chemo Beneficial in High-Risk Ovarian CancerThe addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian ...
There's a potential of supportive care approaches such as nutrition and mental health in improving quality of life during cancer treatment. But clear, evidence-based frameworks are still missing for ...
A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding ...
A partnership between Sheffield Hallam University and Paxman Scalp Cooling which aims to prevent hair loss during ...
The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...
Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.
One woman opens up about her experience with clitoral atrophy after being diagnosed with breast cancer. Here's how she found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results